Wave Life Sciences (WVE) Reports Q2 Loss, Lags Revenue Estimates
WVEWave Life Sciences .(WVE) ZACKS·2024-08-08 21:46

Wave Life Sciences (WVE) came out with a quarterly loss of 0.25pershareversustheZacksConsensusEstimateofalossof0.25 per share versus the Zacks Consensus Estimate of a loss of 0.16. This compares to loss of 0.20pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof−56.250.20 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -56.25%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of 0.18 per share when it actually produced a loss of $0.24, delivering a surprise of -33.33%.Over the last four quarters, th ...